Zhou, J.; Wang, N.; Lin, Y.-K.; Li, Q.-L.; Liu, R.-M.; Hu, J.-Q.; Zhou, H.; Lan, H.; Xie, Y.
Targeting NFAT2 for Reversing the P-gp-Mediated Multidrug Resistance to Paclitaxel by Manidipine. Cancers 2025, 17, 3289.
https://doi.org/10.3390/cancers17203289
AMA Style
Zhou J, Wang N, Lin Y-K, Li Q-L, Liu R-M, Hu J-Q, Zhou H, Lan H, Xie Y.
Targeting NFAT2 for Reversing the P-gp-Mediated Multidrug Resistance to Paclitaxel by Manidipine. Cancers. 2025; 17(20):3289.
https://doi.org/10.3390/cancers17203289
Chicago/Turabian Style
Zhou, Jian, Nan Wang, Yu-Kang Lin, Qi-Lu Li, Rui-Ming Liu, Jia-Qin Hu, Hua Zhou, Hai Lan, and Ying Xie.
2025. "Targeting NFAT2 for Reversing the P-gp-Mediated Multidrug Resistance to Paclitaxel by Manidipine" Cancers 17, no. 20: 3289.
https://doi.org/10.3390/cancers17203289
APA Style
Zhou, J., Wang, N., Lin, Y.-K., Li, Q.-L., Liu, R.-M., Hu, J.-Q., Zhou, H., Lan, H., & Xie, Y.
(2025). Targeting NFAT2 for Reversing the P-gp-Mediated Multidrug Resistance to Paclitaxel by Manidipine. Cancers, 17(20), 3289.
https://doi.org/10.3390/cancers17203289